1 completed, 1 terminated, 1 unknown. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 1, Terminated 1, Unknown 1 |
Follow fotemustine: new trials by email Literature Review of fotemustine trials Research Report on fotemustine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Fotemustine(FTM) Vs FTM and Ipilimumab (IPI) or IPI and Nivolumab in Melanoma Brain Metastasis Fotemustine, Fotemustine and Ipilimumab, Ipilimumab and nivolumab - Brain Metastases | Phase 3 | Unknown | Italian Network for Tumor Biotherapy Foundation | 168 | 2012-12-01 | 2015-06-02 |
| Intravenous or Hepatic Arterial Infusion of Fotemustine in Treating Patients With Unresectable Liver Metastases From Eye Melanoma fotemustine, isolated perfusion - Intraocular Melanoma, Metastatic Cancer | Phase 3 | Terminated | European Organisation for Research and Treatment of Cancer - EORTC | 171 | 2005-01-01 | 2012-09-24 |
| Fotemustine and Dacarbazine Versus Dacarbazine +/- Alpha Interferon in Advanced Malignant Melanoma Dacarbazine, Fotemustine, Interferon Alfa-2b - Malignant Melanoma, Recurrent Melanoma | Phase 3 | Completed | National Cancer Institute, Naples | 269 | 2002-04-01 | 2023-04-11 |
Brain Neoplasms (1) · Melanoma (1) · Neoplasm Metastasis (1) · Uveal Melanoma (1)
European Organisation for Research and Treatment of Cancer - EORTC (1) · Italian Network for Tumor Biotherapy Foundation (1) · National Cancer Institute, Naples (1)
Italy (2) · Poland (1) · Switzerland (1) · United Kingdom (1)
Anna Maria Di Giacomo, PhD,MD (1) · Antonio Daponte, M.D. (1) · Paolo A Ascierto, M.D., Ph.D. (1) · Serge Leyvraz, MD (1) · Simona Signoriello, M.D. (1)
PMID 22027909, PMID 23402397, PMID 24510314
2004 (1)